Effectiveness and safety of acupuncture for migraine: a randomised, single blind and sham controlled trial

Evaluation of effectiveness and safety of acupuncture in the treatment of migraine: a randomised, single blind and sham controlled trial

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000314628

Enrollment

Registered

2005-09-06

Start date

2005-12-09

Completion date

2006-12-01

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This prospective, randomised, patient/assessor blinded, sham-acupuncture controlled clinical trial was conducted at the Clinical Trial Lab of the School of Health sciences, WHO Collaborating Centre for Traditional Medicine, RMIT University, Australia, with the approval of the Human Research Ethics Committee of the RMIT University (Project No. 16/05), . Fifty (50) participants out of 179 enquires were enrolled and randomly allocated into either the real acupuncture (n=26) or the sham acupuncture (n=24) groups.

Interventions

All participants will be randomised into either real acupuncture or sham acupuncture group to receive 16 sessions of treatment over a period of 20 weeks.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

Current history of migraine symptoms; and provision of written consent to participante.

Exclusion criteria

Current pregnancy or malignancy; had acupuncture treatment in the previous 6 months; history of head injury or whiplash; severe arrhythmia or heart filure, brain tumour or epilepsy; and haemophiliac.

Outcome results